BioCentury
ARTICLE | Company News

Taiwan’s JHL to terminate biosimilars programs in Genentech trade secret settlement

September 6, 2019 6:53 PM UTC

JHL Biotech and Genentech have settled a civil suit involving allegations that the Taiwanese start-up stole the Roche unit’s trade secrets.

Under terms of the settlement, JHL Biotech Inc. (Zhubei, Taiwan) has agreed to “abandon development of and destroy all cell lines and cell banks associated with Genentech’s medicines Pulmozyme, Rituxan, Herceptin and Avastin, and cease from disclosing, using or sharing any confidential Genentech information in any way in its business,” according to Genentech’s description of a memorandum of understanding between the two companies...